Arrowhead Research Corporation, a targeted therapeutics company, today announced that the first patient has been dosed in a Phase 1 clinical trial with Adipotide, a new class of treatment for obesity.
URL: http://www.news-medical.net/news/20120711/Arrowhead-initiates-Adipotide-Phase-1-trial-in-obesity.aspx
No comments:
Post a Comment